BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singer JP, Katz PP, Soong A, Shrestha P, Huang D, Ho J, Mindo M, Greenland JR, Hays SR, Golden J, Kukreja J, Kleinhenz ME, Shah RJ, Blanc PD. Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study. Am J Transplant 2017;17:1334-45. [PMID: 27743488 DOI: 10.1111/ajt.14081] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Meregaglia M, Nicod E, Drummond M. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. Eur J Health Econ 2022. [DOI: 10.1007/s10198-022-01541-y] [Reference Citation Analysis]
2 Bourgeois N, Shallwani SM, Al-huda FS, Mathur S, Poirier C, Janaudis-ferreira T. Relationship of Exercise Capacity, Physical Function, and Frailty Measures With Clinical Outcomes and Healthcare Utilization in Lung Transplantation: A Scoping Review. Transplantation Direct 2022;8:e1385. [DOI: 10.1097/txd.0000000000001385] [Reference Citation Analysis]
3 Patel H, Shah JR, Patel DR, Avanthika C, Jhaveri S, Gor K. Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols. Disease-a-Month 2022. [DOI: 10.1016/j.disamonth.2022.101484] [Reference Citation Analysis]
4 Hartzler AL, Bartlett LE, Hobler MR, Reid N, Pryor JB, Kapnadak SG, Berry DL, Lober WB, Goss CH, Ramos KJ; Take on Transplant Study Group . Take on transplant: human-centered design of a patient education tool to facilitate informed discussions about lung transplant among people with cystic fibrosis. J Am Med Inform Assoc 2022:ocac176. [PMID: 36173364 DOI: 10.1093/jamia/ocac176] [Reference Citation Analysis]
5 Perez AA, Shah RJ. Critical Care of the Lung Transplant Patient. Clin Chest Med 2022;43:457-70. [PMID: 36116814 DOI: 10.1016/j.ccm.2022.04.007] [Reference Citation Analysis]
6 Ramos KJ, Hee Wai T, Stephenson AL, Sykes J, Stanojevic S, Rodriguez PJ, Bansal A, Mayer-hamblett N, Goss CH, Kapnadak SG. Development and Internal Validation of a Prognostic Model of the Probability of Death or Lung Transplantation Within 2 Years for Patients With Cystic Fibrosis and FEV1 ≤ 50% Predicted. Chest 2022. [DOI: 10.1016/j.chest.2022.05.021] [Reference Citation Analysis]
7 Kolaitis NA, Gao Y, Soong A, Greenland JR, Hays SR, Golden JA, Venado A, Leard LE, Shah RJ, Kleinhenz ME, Katz PP, Kukreja J, Blanc PD, Smith PJ, Singer JP. Depressive symptoms in lung transplant recipients: trajectory and association with mortality and allograft dysfunction. Thorax 2022:thoraxjnl-2021-217612. [PMID: 35354643 DOI: 10.1136/thoraxjnl-2021-217612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kolaitis NA, Shah RJ. A Comprehensive Guide to Lung Transplantation for the Recipient With Pulmonary Fibrosis. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00080-9] [Reference Citation Analysis]
9 Perez AA, Singer JP. Patient-Centered Outcomes in Lung Transplantation. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00121-9] [Reference Citation Analysis]
10 Perez AA, Leard LE. What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis. J Heart Lung Transplant 2021:S1053-2498(21)02612-7. [PMID: 34973873 DOI: 10.1016/j.healun.2021.11.015] [Reference Citation Analysis]
11 Copeland CR, Lancaster LH. Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD). Front Med (Lausanne) 2021;8:743977. [PMID: 34722582 DOI: 10.3389/fmed.2021.743977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hamada R, Oshima Y, Sato S, Yoshioka Y, Nankaku M, Kondo T, Chen-Yoshikawa TF, Ikeguchi R, Nakajima D, Date H, Matsuda S. Changes in the health-related quality of life and social reintegration status after lung transplantation following hematopoietic stem cell transplantation. Support Care Cancer 2021. [PMID: 34609584 DOI: 10.1007/s00520-021-06592-0] [Reference Citation Analysis]
13 Nöhre M, de Zwaan M, Bauer-Hohmann M, Ius F, Valtin C, Gottlieb J. The Transplant Evaluation Rating Scale Predicts Clinical Outcomes 1 Year After Lung Transplantation: A Prospective Longitudinal Study. Front Psychiatry 2021;12:704319. [PMID: 34512417 DOI: 10.3389/fpsyt.2021.704319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kapnadak SG, Ramos KJ, Dellon EP. Enhancing care for individuals with advanced cystic fibrosis lung disease. Pediatr Pulmonol 2021;56 Suppl 1:S69-78. [PMID: 32609949 DOI: 10.1002/ppul.24937] [Reference Citation Analysis]
15 Piechura LM, Rinewalt DE, Mallidi HR. Advanced Surgical and Percutaneous Approaches to Pulmonary Vascular Disease. Clin Chest Med 2021;42:143-54. [PMID: 33541608 DOI: 10.1016/j.ccm.2020.10.003] [Reference Citation Analysis]
16 Lyu DM, Goff RR, Chan KM. The Lung Allocation Score and Its Relevance. Semin Respir Crit Care Med 2021;42:346-56. [PMID: 34030198 DOI: 10.1055/s-0041-1729541] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
17 Ramos KJ, Sykes J, Stanojevic S, Ma X, Ostrenga JS, Fink A, Quon BS, Marshall BC, Faro A, Petren K, Elbert A, Goss CH, Stephenson AL. Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries. Chest 2021:S0012-3692(21)00697-8. [PMID: 33878343 DOI: 10.1016/j.chest.2021.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
18 Eichenlaub M, Ruettner B, Seiler A, Jenewein J, Boehler A, Benden C, Wutzler U, Goetzmann L. The Actualization of the Transplantation Complex on the Axis of Psychosomatic Totality-Results of a Qualitative Study. Healthcare (Basel) 2021;9:455. [PMID: 33921523 DOI: 10.3390/healthcare9040455] [Reference Citation Analysis]
19 DeBolt CL, Gao Y, Sutter N, Soong A, Leard L, Jeffrey G, Kleinhenz ME, Calabrese D, Greenland J, Venado A, Hays SR, Shah R, Kukreja J, Trinh B, Kolaitis NA, Douglas V, Diamond JM, Smith P, Singer J. The association of post-operative delirium with patient-reported outcomes and mortality after lung transplantation. Clin Transplant 2021;35:e14275. [PMID: 33682171 DOI: 10.1111/ctr.14275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Esendagli D, Shah U, Batihan G, Magouliotis D, Meloni F, Vos R, Elia S, Hellemons M. ERS International Congress 2020: highlights from the Thoracic Surgery and Transplantation Assembly. ERJ Open Res 2021;7:00743-2020. [PMID: 33748258 DOI: 10.1183/23120541.00743-2020] [Reference Citation Analysis]
21 Hoover J, Mintz MA, Deiter F, Aminian E, Chen J, Hays SR, Singer JP, Calabrese DR, Kukreja J, Greenland JR. Rapid molecular detection of airway pathogens in lung transplant recipients. Transpl Infect Dis 2021;:e13579. [PMID: 33523538 DOI: 10.1111/tid.13579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Neely ML, Palmer SM, Snyder LD. Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing. Am J Transplant 2021;21:456-7. [PMID: 32957167 DOI: 10.1111/ajt.16313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Kolaitis NA, Gao Y, Soong A, Greenland JR, Hays SR, Golden J, Leard LE, Shah RJ, Kleinhenz ME, Katz PP, Venado A, Kukreja J, Blanc PD, Singer JP. Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression. Am J Transplant 2021;21:815-24. [PMID: 32794295 DOI: 10.1111/ajt.16257] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Smith PJ, Dunitz JM, Lucy A, Hempstead SE, Tallarico E, Faro A, Pilewski JM, Ramos KJ. Incorporating patient and caregiver feedback into lung transplant referral guidelines for individuals with cystic fibrosis-Preliminary findings from a novel paradigm. Clin Transplant 2020;34:e14038. [PMID: 32654238 DOI: 10.1111/ctr.14038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bande D, Moltó L, Pereira JA, Montes A. Chronic pain after groin hernia repair: pain characteristics and impact on quality of life. BMC Surg 2020;20:147. [PMID: 32631293 DOI: 10.1186/s12893-020-00805-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Dugger DT, Fung M, Zlock L, Caldera S, Sharp L, Hays SR, Singer JP, Leard LE, Golden JA, Shah RJ, Kukreja J, Gordon E, Finkbeiner W, Kleinhenz ME, Langelier C, Greenland JR. Cystic Fibrosis Lung Transplant Recipients Have Suppressed Airway Interferon Responses during Pseudomonas Infection. Cell Rep Med 2020;1:100055. [PMID: 32754722 DOI: 10.1016/j.xcrm.2020.100055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
27 Jaksch P, Hoetzenecker K. Lungentransplantation. Pneumologe 2020;17:285-296. [DOI: 10.1007/s10405-020-00330-9] [Reference Citation Analysis]
28 Trindade AJ, Thaniyavarn T, Townsend K, Klasek R, Tsveybel KP, Kennedy JC, Goldberg HJ, El-Chemaly S. Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres. Front Immunol 2020;11:1063. [PMID: 32547557 DOI: 10.3389/fimmu.2020.01063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Venado A, Kolaitis NA, Huang CY, Gao Y, Glidden DV, Soong A, Sutter N, Katz PP, Greenland JR, Calabrese DR, Hays SR, Golden JA, Shah RJ, Leard LE, Kukreja J, Deuse T, Wolters PJ, Covinsky K, Blanc PD, Singer JP. Frailty after lung transplantation is associated with impaired health-related quality of life and mortality. Thorax 2020;75:669-78. [PMID: 32376733 DOI: 10.1136/thoraxjnl-2019-213988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
30 Kapnadak SG, Dimango E, Hadjiliadis D, Hempstead SE, Tallarico E, Pilewski JM, Faro A, Albright J, Benden C, Blair S, Dellon EP, Gochenour D, Michelson P, Moshiree B, Neuringer I, Riedy C, Schindler T, Singer LG, Young D, Vignola L, Zukosky J, Simon RH. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. Journal of Cystic Fibrosis 2020;19:344-54. [DOI: 10.1016/j.jcf.2020.02.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 24.5] [Reference Citation Analysis]
31 Barac YD, Mulvihill MS, Jawitz O, Klapper J, Haney J, Daneshmand M, Nasir B, Chen D, Milano CA, Hartwig MG. Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation. Ann Thorac Surg 2020;110:414-23. [PMID: 32251655 DOI: 10.1016/j.athoracsur.2020.02.061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Perez AA, Hays SR, Soong A, Gao Y, Greenland JR, Leard LE, Shah RJ, Golden J, Kukreja J, Venado A, Kleinhenz ME, Singer JP. Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis. Pediatr Pulmonol 2020;55:1406-13. [PMID: 32237273 DOI: 10.1002/ppul.24747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Shah VH, Rao MK. Changing Landscape of Solid Organ Transplantation for Older Adults: Trends and Post-Transplant Age-Related Outcomes. Curr Transpl Rep 2020;7:38-45. [DOI: 10.1007/s40472-020-00275-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
34 Tokuno J, Chen-Yoshikawa TF, Oga T, Oto T, Okawa T, Okada Y, Akiba M, Ikeda M, Nakajima D, Hamaji M, Motoyama H, Aoyama A, Isomi M, Chin K, Date H. Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation. Can Respir J 2020;2020:4912920. [PMID: 32211085 DOI: 10.1155/2020/4912920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Blumenthal JA, Smith PJ, Sherwood A, Mabe S, Snyder L, Frankel C, McKee DC, Hamilton N, Keefe FJ, Shearer S, Schwartz J, Palmer S. Remote Therapy to Improve Outcomes in Lung Transplant Recipients: Design of the INSPIRE-III Randomized Clinical Trial. Transplant Direct 2020;6:e535. [PMID: 32195326 DOI: 10.1097/TXD.0000000000000979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mulvihill MS, Lee HJ, Weber J, Choi AY, Cox ML, Yerokun BA, Bishawi MA, Klapper J, Kuchibhatla M, Hartwig MG. Variability in donor organ offer acceptance and lung transplantation survival. J Heart Lung Transplant 2020;39:353-62. [PMID: 32029400 DOI: 10.1016/j.healun.2019.12.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
37 Singer JP, Soong A, Chen J, Shrestha P, Zhuo H, Gao Y, Greenland JR, Hays SR, Kukreja J, Golden J, Gregorich SE, Stewart AL. Development and Preliminary Validation of the Lung Transplant Quality of Life (LT-QOL) Survey. Am J Respir Crit Care Med 2019;199:1008-19. [PMID: 30303408 DOI: 10.1164/rccm.201806-1198OC] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
38 Smith PJ, Browndyke JN. The Neuropsychology of Pulmonary Disease and Lung Transplantation Complications. Neurovascular Neuropsychology 2020. [DOI: 10.1007/978-3-030-49586-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kumar A. Overview of Lung Transplant. Clinical Thoracic Anesthesia 2020. [DOI: 10.1007/978-981-15-0746-5_17] [Reference Citation Analysis]
40 Kukreja J, Tsou S, Chen J, Trinh BN, Feng C, Golden JA, Hays S, Deuse T, Singer JP, Brzezinski M. Risk Factors and Outcomes of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation. Seminars in Thoracic and Cardiovascular Surgery 2020;32:772-85. [DOI: 10.1053/j.semtcvs.2020.05.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
41 Nokes B, Golts E, Afshar K. Lung Transplant for Interstitial Lung Diseases. Interstitial Lung Diseases 2019. [DOI: 10.5772/intechopen.82722] [Reference Citation Analysis]
42 Smith PJ, Frankel CW, Bacon DR, Bush E, Mentz RJ, Snyder LD. Depressive symptoms, physical activity, and clinical events: The ADAPT prospective pilot study. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
43 Spagnolo P, Griese M, Cocconcelli E, Bernardinello N, Bush A. Abandoning developmental silos: what can paediatricians and adult interstitial lung disease physicians learn from each other? Curr Opin Pulm Med 2019;25:418-25. [PMID: 31365375 DOI: 10.1097/MCP.0000000000000594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Nöhre M, Albayrak Ö, Brederecke J, Claes L, Smits D, Tudorache I, de Zwaan M. Psychometric Properties of the German Version of the Pulmonary-Specific Quality-of-Life Scale in Lung Transplant Patients. Front Psychiatry 2019;10:374. [PMID: 31214059 DOI: 10.3389/fpsyt.2019.00374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Mohindru B, Turner D, Sach T, Bilton D, Carr S, Archangelidi O, Bhadhuri A, Whitty JA. Health State Utility Data in Cystic Fibrosis: A Systematic Review. Pharmacoecon Open 2020;4:13-25. [PMID: 31054048 DOI: 10.1007/s41669-019-0144-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Perez AA, Singer JP, Schwartz BS, Chin‐hong P, Shah RJ, Kleinhenz ME, Gao Y, Venado A, Leard LE, Golden JA, Kukreja J, Greenland JR, Hays SR. Management and clinical outcomes after lung transplantation in patients with pre‐transplant Mycobacterium abscessus infection: A single center experience. Transpl Infect Dis 2019;21:e13084. [DOI: 10.1111/tid.13084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
47 Swigris JJ. A New Tool to Capture Patients' Perceptions of the Effects of Lung Transplantation. Am J Respir Crit Care Med 2019;199:941-3. [PMID: 30457877 DOI: 10.1164/rccm.201810-2001ED] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Venado A, McCulloch C, Greenland JR, Katz P, Soong A, Shrestha P, Hays S, Golden J, Shah R, Leard LE, Kleinhenz ME, Kukreja J, Zablotska L, Allen IE, Covinsky K, Blanc P, Singer JP. Frailty trajectories in adult lung transplantation: A cohort study. J Heart Lung Transplant 2019;38:699-707. [PMID: 31005571 DOI: 10.1016/j.healun.2019.03.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
49 Pearson R. How to Measure Success. Essentials in Lung Transplantation 2019. [DOI: 10.1007/978-3-319-90933-2_16] [Reference Citation Analysis]
50 Sauleda J, Núñez B, Sala E, Soriano JB. Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes. Med Sci (Basel) 2018;6:E110. [PMID: 30501130 DOI: 10.3390/medsci6040110] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
51 Smith BK, Carter N, Arteaga A, Dinh AC, Martin AD. Acute and 6-Month Outcomes in Recipients of Lung Transplantation Following Lower Extremity Strength Training: Pilot Study. Journal of Acute Care Physical Therapy 2018;9:145-154. [DOI: 10.1097/jat.0000000000000081] [Reference Citation Analysis]
52 Laporta Hernandez R, Aguilar Perez M, Lázaro Carrasco MT, Ussetti Gil P. Lung Transplantation in Idiopathic Pulmonary Fibrosis. Med Sci (Basel) 2018;6:E68. [PMID: 30142942 DOI: 10.3390/medsci6030068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
53 Rynar LZ, Merchant MS, Dilling DF. Suicidal ideation in lung transplant recipients: A case series. Clin Transplant 2018;32:e13263. [PMID: 29665073 DOI: 10.1111/ctr.13263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Smith PJ, Byrd R, Lusby M, Clausen E, Snyder LD. Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation. Psychosom Med 2018;80:403-9. [DOI: 10.1097/psy.0000000000000573] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
55 Smith PJ, Stonerock GL, Ingle KK, Saulino CK, Hoffman B, Wasserman B, Blumenthal JA, Palmer SM, Klapper JA, Hartwig MG, Esposito VR, Snyder LD. Neurological Sequelae and Clinical Outcomes After Lung Transplantation. Transplant Direct 2018;4:e353. [PMID: 29707624 DOI: 10.1097/TXD.0000000000000766] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
56 Kolaitis NA, Soong A, Shrestha P, Zhuo H, Neuhaus J, Katz PP, Greenland JR, Golden J, Leard LE, Shah RJ, Hays SR, Kukreja J, Kleinhenz ME, Blanc PD, Singer JP. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation. J Thorac Cardiovasc Surg 2018;156:440-448.e2. [PMID: 29550072 DOI: 10.1016/j.jtcvs.2018.01.101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
57 Maldonado DA, RoyChoudhury A, Lederer DJ. A novel patient-centered "intention-to-treat" metric of U.S. lung transplant center performance. Am J Transplant 2018;18:226-31. [PMID: 28862792 DOI: 10.1111/ajt.14486] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
58 Courtwright A, Cantu E. Lung transplantation in elderly patients. J Thorac Dis 2017;9:3346-51. [PMID: 29221319 DOI: 10.21037/jtd.2017.08.31] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
59 Thabut G, Mal H. Outcomes after lung transplantation. J Thorac Dis 2017;9:2684-91. [PMID: 28932576 DOI: 10.21037/jtd.2017.07.85] [Cited by in Crossref: 85] [Cited by in F6Publishing: 95] [Article Influence: 17.0] [Reference Citation Analysis]